Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV (Q79152244)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

3

Paula J Biesta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

5

Harry L A Janssen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Renate G. van der Molen

series ordinal

1

object named as

Renate G van der Molen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

4

Johannes G Kusters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

2

Dave Sprengers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

0 references

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

907-914

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B virus. The major etiology of hepatocellular carcinoma

19 December 2019

cites work

1 reference

7 January 2021

1 reference

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

7 January 2021

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

1 reference

7 January 2021

Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection

1 reference

7 January 2021

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

7 January 2021

Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

1 reference

7 January 2021

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

1 reference

7 January 2021

Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T-cell responses in vitro and in vivo

1 reference

7 January 2021

Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection

1 reference

7 January 2021

Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection

1 reference

7 January 2021

T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification

1 reference

7 January 2021

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

7 January 2021

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays

1 reference

7 January 2021

A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen

1 reference

7 January 2021

Immune tolerance split between hepatitis B virus precore and core proteins

1 reference

7 January 2021

HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection

1 reference

7 January 2021

Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease

1 reference

7 January 2021

Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases

1 reference

7 January 2021

The B7 family revisited

1 reference

7 January 2021

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

7 January 2021

IL-12 and IL-23: master regulators of innate and adaptive immunity.

1 reference

7 January 2021

Mechanisms of interleukin-10-mediated immune suppression

1 reference

7 January 2021

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

7 January 2021

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17006907%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference